The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
about
HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilitiesHuman CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokinesInnovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide AnalysesCharacteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious DiseasesStructural basis for a major histocompatibility complex class Ib-restricted T cell responseEpstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patientsMycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activityIdentification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.Mammalian non-classical major histocompatibility complex I and its receptors: Important contexts of gene, evolution, and immunity.HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice.The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft RejectionHLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytesImmunological similarities between implantation and pre-eclampsia.Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cellsHLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cellsHLA-E(⁎)01:03 Allele in Lung Transplant Recipients Correlates with Higher Chronic Lung Allograft Dysfunction Occurrence.The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.HLA-E: a novel player for histocompatibility.Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cellsNLRP2 is a suppressor of NF-ƙB signaling and HLA-C expression in human trophoblasts†,‡.Markers and function of human NK cells in normal and pathological conditions.HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells.A conserved energetic footprint underpins recognition of Human Leukocyte Antigen-E by two distinct αβ T cell receptors.The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques.T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytesHLA-E Peptide Repertoire and Dimorphism-Centerpieces in the Adaptive NK Cell Puzzle?
P2860
Q24314932-D48A7BCB-B069-4696-81C0-01A1B1504270Q24316479-1D1FD61C-C94C-4083-B278-717EAF68073EQ27027110-924A37FD-7DF4-431B-BC96-003786C28CC2Q28079186-084D633D-2864-4690-83F1-316956EC4FD2Q28941762-6CCD2F7E-4BDA-4675-B660-18E0DE521394Q31104121-26DADE26-4DB4-4FA5-B5F1-F8EA9CA43591Q33535876-1C900396-4CAB-4263-958A-AFE5217B9E5EQ34038159-8AC6BA3D-D7D6-4DE7-B146-98249E0AE617Q34494545-91D39EE6-6C2D-47B9-8C7D-3607BC7B7E0BQ34506165-8D056F69-A434-46EF-B129-CD4DDE464460Q34550146-2D937CA8-F523-4771-A672-B3650AE1308DQ35753770-AE148466-B38D-41A5-A4F0-F04628735A53Q35978622-04936DCE-E221-48CC-9A1B-8FC6BCE6085FQ36099549-F7A85690-F4D8-4EBB-B140-0E1EFBCFB033Q36244210-E93E6DB6-C25A-41B2-A5C2-0AC25531FC40Q36371913-45FBAE0A-02BD-46A9-85D3-11DC954B7E05Q37140147-B822A367-8999-4FC0-B1E8-BA2554E3E970Q37773161-AE6E1048-5FF7-4464-8DE4-E7861531869FQ38151057-B23F4F98-378D-4FB8-925C-6BD7589FA287Q38268679-01FC061F-3372-46D5-B39B-D8AC2BE12BE0Q38585054-9AB87DCA-2485-4337-8271-B1E42E049549Q38585283-01D5179A-9B22-41A9-BE57-5B3F83C7F6C2Q38710699-8468D551-BC14-4F9D-8FF7-D6D17C2C31E9Q39068084-39018AE7-DBA2-444C-936B-3F8BD21E3254Q40147542-BE4EE179-D9C9-4F1E-9C5F-B5B90547D0FCQ41925659-AF50799D-C19B-4501-B9B7-AFCCCD1C77DEQ45874664-C9BFE9DB-4461-4174-9056-160673BCE4B7Q46254045-7CC3AF20-29EE-4D8D-B181-1B72B4B1F58CQ57369861-B7EC1401-EDB2-4FB6-8234-ADDFD961AEEEQ58606323-4C1E3DD9-70F2-4D7C-8B6D-27E9B8940AEB
P2860
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The analysis of the natural ki ...... pha/beta-mediated recognition.
@ast
The analysis of the natural ki ...... pha/beta-mediated recognition.
@en
The analysis of the natural ki ...... pha/beta-mediated recognition.
@nl
type
label
The analysis of the natural ki ...... pha/beta-mediated recognition.
@ast
The analysis of the natural ki ...... pha/beta-mediated recognition.
@en
The analysis of the natural ki ...... pha/beta-mediated recognition.
@nl
prefLabel
The analysis of the natural ki ...... pha/beta-mediated recognition.
@ast
The analysis of the natural ki ...... pha/beta-mediated recognition.
@en
The analysis of the natural ki ...... pha/beta-mediated recognition.
@nl
P2093
P2860
P1476
The analysis of the natural ki ...... pha/beta-mediated recognition.
@en
P2093
Biassoni R
Castriconi R
Mingari MC
Romagnani C
P2860
P304
P356
10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C
P407
P577
2001-12-01T00:00:00Z